Thyroid-stimulating hormone–body mass index profile and mortality in metabolic dysfunction-associated steatotic liver disease
Background and aims Thyroid-stimulating hormone (TSH) and body mass index (BMI) are potential prognostic factors in metabolic dysfunction-associated steatotic liver disease (MASLD). We investigated whether a combined TSH–BMI profile could refine risk stratification and identify lifestyle patterns associated with favora...